Status:
COMPLETED
Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients
Lead Sponsor:
IVI Madrid
Conditions:
Infertility
Eligibility:
FEMALE
18-38 years
Phase:
PHASE4
Brief Summary
The recent controversy regarding the use of pill for cycle planning in GnRH antagonists IVF cycle has driven the search for new ways to plan IVF cycles in order to avoid weekends or to equally distrib...
Eligibility Criteria
Inclusion
- 1st or 2nd IVF cycle
- BMI \<30 kg/m2
- regular menstrual cycles
- basal FSH \<10IU and E2 \<60pg/mL
Exclusion
- polycystic ovaries
- endometriosis
- previous ovarian surgery
- previous low ovarian response
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT01501448
Start Date
January 1 2012
End Date
February 1 2013
Last Update
March 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Madrid
Madrid, Madrid, Spain, 28223